STOCK TITAN

Cronos Group (CRON) executive converts RSUs to shares, withholds stock for taxes

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Cronos Group Inc. executive Anna Shlimak exercised 47,368 restricted stock units (RSUs) into an equal number of common shares. The RSUs had a conversion price of $0.00 per share, reflecting a routine vesting event rather than an open‑market purchase.

To cover tax obligations related to this vesting, 17,230 common shares were withheld at a reported price of $2.56 per share, which is not an open‑market sale. After these transactions, Shlimak directly holds 311,061 common shares and 460,548 RSUs. A prior grant of 142,105 RSUs vests in three substantially equal annual installments beginning on the first anniversary of its grant date.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Shlimak Anna

(Last) (First) (Middle)
4491 CONCESSION RD 12

(Street)
STAYNER A6 L0M 1S0

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Cronos Group Inc. [ CRON ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
See Remarks
3. Date of Earliest Transaction (Month/Day/Year)
03/12/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
COMMON SHARES 03/12/2026 M 47,368 A $0(1) 328,291 D
COMMON SHARES 03/12/2026 F 17,230 D $2.56 311,061 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
RESTRICTED STOCK UNITS (1) 03/12/2026 M 47,368 (2) (2) COMMON SHARES 47,368 $0 460,548 D
Explanation of Responses:
1. Each restricted stock unit ("RSU") represents a contingent right to receive one common share of Cronos Group Inc.
2. On March 12, 2025, the Reporting Person was granted 142,105 RSUs, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
Remarks:
Chief Financial Officer
/s/ Aaron Werner, as attorney-in-fact for Anna Shlimak 03/16/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Cronos Group (CRON) report for Anna Shlimak?

Cronos Group reported that executive Anna Shlimak exercised 47,368 RSUs into common shares at $0.00 per share. This was a routine equity compensation vesting, not an open‑market share purchase, and increased her direct common share holdings.

Did Anna Shlimak sell any Cronos Group (CRON) shares in this Form 4?

No open‑market sale occurred. Instead, 17,230 common shares were disposed of under code F, meaning they were withheld by the company to pay tax obligations on the RSU vesting. This is a tax settlement mechanism, not a discretionary sale.

How many Cronos Group (CRON) shares does Anna Shlimak hold after these transactions?

Following the reported transactions, Anna Shlimak directly holds 311,061 common shares of Cronos Group. She also has 460,548 RSUs outstanding, each representing a contingent right to receive one common share, according to the disclosure.

What do the exercised RSUs represent for Cronos Group (CRON) executive Anna Shlimak?

Each RSU represents a contingent right to receive one Cronos Group common share. By exercising 47,368 RSUs, Anna Shlimak converted those units into the same number of common shares as part of her equity compensation package, with no cash exercise price.

Was there a prior Cronos Group (CRON) RSU grant mentioned for Anna Shlimak?

Yes. The disclosure notes that on March 12, 2025, Anna Shlimak was granted 142,105 RSUs. These RSUs vest in three substantially equal annual installments, beginning on the first anniversary of the grant date, creating a multi‑year vesting schedule.

Does this Cronos Group (CRON) Form 4 indicate any remaining derivative holdings for Anna Shlimak?

Yes. After the reported RSU exercise, the filing shows 460,548 RSUs remaining for Anna Shlimak. These unvested or unexercised RSUs continue to represent potential future issuances of common shares as they vest under the applicable terms.
Cronos Group

NASDAQ:CRON

View CRON Stock Overview

CRON Rankings

CRON Latest News

CRON Latest SEC Filings

CRON Stock Data

962.79M
193.91M
Drug Manufacturers - Specialty & Generic
Medicinal Chemicals & Botanical Products
Link
Canada
STAYNER